Portfolio Rapha Capital Management

Celgene vet Barer lines up a $23M startup round for next-gen I/O tech out of Johns Hopkins

By Kevin SlawinJanuary 2, 2018February 4th, 2021No Comments

NexImmune
Celgene vet Barer lines up a $23M startup round for next-gen I/O tech out of Johns Hopkins
January 2, 2018

Previous PostPoseida raises $30.5 million for cancer cell therapy
Next PostVersum Materials and NuMat Technologies to Commercialize Next-Generation Adsorbent Technology for Delivery of Dopant Gases

© 2024 Ponce Therapeutics. Privacy Policy | Terms & Conditions